Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization.

K, Heerlein; Giorgi S, De; G, Degraeve; T, Frodl; W, Hagedoorn; AJ, Oliveira-Maia; C, Otte; Sola V, Perez; S, Rathod; G, Rosso; P, Sierra; A, Vita; J, Morrens; B, Rive; Haughey S, Mulhern; Y, Kambarov; AH, Young

doi:10.1016/j.jad.2021.11.004

Public

Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization.

Shared by NobleBlocks on Nov 4, 2021 • 12:00 AM UTC

Authors:

Heerlein K

De Giorgi S

Degraeve G

Abstract

<h4>Background</h4>Treatment resistant depression (TRD) is diagnosed when patients experiencing a major depressive episode fail to respond to ≥2 treatments. Along with substantial indirect costs, patients with TRD have higher healthcare resource utilization (HCRU) than other patients with depression...

Subject

Major Depressive Disorder

Treatment Resistant Depression

Observational Study

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!